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Optimal Down Regulation of mRNA Translation
Yoram Zarai, Michael Margaliot, and Tamir Tuller
Abstract
Down regulation of mRNA translation is an important problem in various bio-medical domains ranging from
developing effective medicines for tumors and for viral diseases to developing attenuated virus strains that can be
used for vaccination. Here, we study the problem of down regulation of mRNA translation using a mathematical
model called the ribosome flow model (RFM). In the RFM, the mRNA molecule is modeled as a chain of n sites.
The flow of ribosomes between consecutive sites is regulated by n + 1 transition rates. Given a set of feasible
transition rates, that models the outcome of all possible mutations, we consider the problem of maximally down
regulating the translation rate by altering the rates within this set of feasible rates. Under certain conditions on the
feasible set, we show that an optimal solution can be determined efficiently. We also rigorously analyze two special
cases of the down regulation optimization problem. Our results suggest that one must focus on the position along
the mRNA molecule where the transition rate has the strongest effect on the protein production rate. However, this
rate is not necessarily the slowest transition rate along the mRNA molecule. We discuss some of the biological
implications of these results.
INTRODUCTION
Gene expression is the process by which the genetic code inscribed in the DNA is transformed into
proteins. The process consists of four main steps: transcription of a DNA gene into an mRNA molecule,
translation of the mRNA molecule to a protein, degradation of mRNA molecules, and degradation of
proteins. During mRNA translation, macromolecules called ribosomes move unidirectionally along the
mRNA molecule, decoding it codon by codon into a corresponding chain of amino acids that is folded
to become a functional protein. Translation is a fundamental biological process, and understanding and
re-engineering this process is important in many scientific disciplines including medicine, evolutionary
biology, and synthetic biology [1].
New methods that measure gene-specific translation activity at the whole-genome scale, like polysome
profiling [2] and ribosome profiling [3], have led to a growing interest in mathematical models for
translation. Such models can be used to integrate and explain the rapidly accumulating biological data as
well as to predict the outcome of various manipulations of the genetic machinery. Recent methods that
allow real-time imaging of translation on a single mRNA transcript in vivo (see, e.g. [4], [5], [6], [7])
are expected to provide even more motivation for developing and analyzing powerful dynamical models
of translation.
Down-regulation of translation is important in cell biology, medicine, and biotechnology. For example,
in many organisms small RNA genes, such as microRNAs, hybridize to the mRNA in specific locations [8],
[9] in order to down-regulate translation initiation or elongation [10], [11] and/or promote mRNA degra-
dation. Alterations in the expression of microRNA genes contribute to the pathogenesis of most, if not all,
human malignancies [12], and many times cancer cells are targeted via generating tumor specific RNA
interference (RNAi) genes that down-regulate the oncogenes [13], [14], [15]. Furthermore, many viral
therapeutic treatments and viral vaccines are based on the attenuation of mRNA translation in the viral
genes [16], [17], [18], [19], [20]. Down regulation of mRNA translation in an optimal manner is also
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2Fig. 1. The RFM models unidirectional flow along a chain of n sites. The state variable xi(t) ∈ [0, 1] represents the density of site i at
time t. The parameter λi > 0 controls the transition rate from site i to site i+1, with λ0 > 0 [λn > 0] controlling the initiation [exit] rate.
The output rate at time t is R(t) = λnxn(t).
related to fundamental biomedical topics such as molecular evolution and functional genomics [21], [22],
[23].
Here we study for the first time optimal down regulation of translation in a dynamical model of
translation. A standard model for translation is the totally asymmetric simple exclusion process (TASEP)
[24], [25]. In this model, particles hop randomly along an ordered lattice of sites. Simple exclusion means
that a particle cannot hop into a site that is occupied by another particle. This models hard exclusion
between the particles, and creates an indirect coupling between the particles. Indeed, if a particle remains
in the same site for a long time then all the particles preceding this site cannot move forward leading to
a “traffic jam”.
In the context of translation, the lattice is the mRNA molecule; the particles are the ribosomes; and hard
exclusion means that a ribosome cannot move forward if the codon in front of it is covered by another
ribosome. In the homogeneous TASEP (HTASEP) all the transition rates within the lattice are assumed to
be equal and normalized to 1, and thus the model is specified by an input rate α, an exit rate β, and an
order N denoting the number of sites in the lattice. TASEP is a fundamental model in non-equilibrium
statistical mechanics that has been used to model numerous natural and artificial processes including traffic
flow, surface growth, communication networks, evacuation dynamics and more [26], [27].
The ribosome flow model (RFM) [28] is a nonlinear, continuous-time compartmental model for the
unidirectional flow of “material” along a chain of n consecutive compartments (or sites). It can be derived
via a mean-field approximation of TASEP [26], [29]. In the RFM, the state variable xi(t) : R+ → [0, 1],
i = 1, . . . , n, describes the normalized amount (or density) of “material” in site i at time t, where
xi(t) = 1 [xi(t) = 0] indicates that site i is completely full [completely empty] at time t. Thus, the
vector x(t) :=
[
x1(t) . . . xn(t)
]′ describes the density profile along the chain at time t. A parameter λi >
0, i = 0, . . . , n, controls the transition rate from site i to site i+ 1, where λ0 [λn] is the initiation [exit]
rate (see Fig. 1). The output rate at time t is R(t) = λnxn(t). In the context of translation, the “material”
are the moving ribosomes, and each site represents a group of codons, i.e. the mRNA is coarse-grained
into n consecutive sites of codons. Thus, R(t), the output flow of ribosomes at time t, is the protein
production rate at time t. It is known that the RFM admits a unique steady-state production rate denoted
by R = R(λ) [30], where λ := [λ0 . . . λn]′.
Here, we use the RFM to analyze how to maximally down-regulate mRNA translation. To do this,
we formulate the following general optimization problem. Given an mRNA molecule with n sites, and a
convex and compact region of feasible transition rates Ωn+1, find a vector λ∗ ∈ Ωn+1 such that R(λ∗) =
minλ∈Ωn+1 R(λ). In other words, the problem is how to select transition rates, within a feasible region,
such that the production rate is minimized (see Fig. 2). To the best of our knowledge, this is the first time
that such a problem is analyzed in a dynamical model of mRNA translation.
As a concrete example, consider an RFM with dimension n and rates λ¯0, . . . , λ¯n. Given a “total reduction
budget” b ∈ [0,min{λ¯i}], define the feasible set Ωn+1 ⊂ Rn+1+ by{[
λ¯0 − ε0 . . . λ¯n − εn
]
: εi ≥ 0, ε0 + · · ·+ εn = b
}
.
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Fig. 2. The problem we consider is how to efficiently select transition rates along the mRNA molecule, within a given set of possible
rates, such that the protein production rate is minimized. In practice, translation rate modification can be done by introducing mutations into
the gene or by designing a corresponding RNAi molecule.
In other words, the feasible set is the set of all the rates obtained by applying a “total reduction budget” b
in the rates of the given mRNA molecule. The question is how to distribute the total reduction budget
over the rates so as to obtain the minimal possible protein production rate. We prove that:
• If some rate λ¯k is a “bottleneck” rate, in a sense that will be made precise below, then an optimal
reduction in protein production rate is obtained by using all the reduction budget b to further
decrease λ¯k;
• If all the given rates are equal, i.e. λ¯0 = · · · = λ¯n, then the transition rate at the middle of the mRNA
molecule is the bottleneck rate, and thus an optimal reduction in protein production rate is obtained
by using all the reduction budget to reduce this transition rate.
Thus, in this case there exists a single site such that mutating it yields the maximal inhibition of translation.
Our results allow to determine where this site is located.
The remainder of this paper is organized as follows. We first briefly review some known results on
the RFM that are needed for our purposes. The following section poses the problem of down-regulating
the steady-state protein production rate in the RFM in an optimal manner, and then describes our main
results. Analysis of the RFM is non-trivial, as this is a nonlinear dynamical model. In particular, the
mapping from λ to R(λ) is nonlinear and does not admit a closed-form expression. Nevertheless, by
combining tools from convex optimization and eigenvalue sensitivity theory, we show that this optimization
problem is tractable in some cases, and rigorously prove several results that have interesting biological
implications. The final section summarizes and describes several directions for further research. To increase
the readability of this paper, all the proofs are placed in the Appendix.
4RIBOSOME FLOW MODEL
The dynamics of the RFM with n sites is given by n nonlinear first-order ordinary differential equations:
x˙1 = λ0(1− x1)− λ1x1(1− x2),
x˙2 = λ1x1(1− x2)− λ2x2(1− x3),
x˙3 = λ2x2(1− x3)− λ3x3(1− x4),
.
.
.
x˙n−1 = λn−2xn−2(1− xn−1)− λn−1xn−1(1− xn),
x˙n = λn−1xn−1(1− xn)− λnxn. (1)
If we define x0(t) := 1 and xn+1(t) := 0 then (1) can be written more succinctly as
x˙i = λi−1xi−1(1− xi)− λixi(1− xi+1), i = 1, . . . , n. (2)
Eq. (2) can be explained as follows. The flow of material from site i to site i+1 at time t is λixi(t)(1−
xi+1(t)). This flow is proportional to xi(t), i.e. it increases with the density at site i, and to (1−xi+1(t)),
i.e. it decreases as site i + 1 becomes fuller. This corresponds to a “soft” version of a simple exclusion
principle. Note that the maximal possible flow from site i to site i+ 1 is the transition rate λi.
Let x(t, a) denote the solution of (1) at time t ≥ 0 for the initial condition x(0) = a. Since the state-
variables correspond to normalized density levels, with xi(t) = 0 [xi(t) = 1] representing that site i is
completely empty [full] at time t, we always assume that a belongs to the closed n-dimensional unit cube:
Cn := {x ∈ Rn : xi ∈ [0, 1], i = 1, . . . , n}. Let int(Cn) [∂Cn] denote the interior [boundary] of Cn. It is
straightforward to verify that ∂Cn is repelling, i.e. if a ∈ ∂Cn then x(t, a) ∈ int(Cn) for all t > 0, so Cn
and also int(Cn) are invariant sets for the dynamics.
An important property of the RFM is the symmetry between the “particles” (i.e. ribosomes) moving
from left to right and “holes” (i.e. ”lack” of ribosomes) moving from right to left (in the TASEP literature,
this property is sometimes referred to as the “particle-hole” symmetry). Indeed, let qj(t) := 1−xn+1−j(t),
i = 1, . . . , n. Then
q˙1 = λn(1− q1)− λn−1q1(1− q2),
q˙2 = λn−1q1(1− q2)− λn−2q2(1− q3),
.
.
.
q˙n = λ1qn−1(1− qn)− λ0qn.
This is another RFM, but now with rates λn, . . . , λ0.
The RFM has been used to model and analyze the flow of ribosomes along the mRNA molecule
during the process of mRNA translation. The (soft) simple exclusion principle corresponds to the fact that
ribosomes have volume and cannot overtake one another.
It is important to mention that it has been shown in [28] that the correlation between the production
rate based on modeling using RFM and using TASEP over all S. cerevisiae endogenous genes is 0.96.
In addition, it has also been shown there that the RFM model agrees well with biological measurements
of ribosome densities. Furthermore, it was also shown that the RFM model predictions correlate well
(correlations up to 0.6) with protein levels in various organisms (e.g. E. coli, S. pombe, S. cerevisiae).
Given the high levels of bias and noise in measurements related to gene expression and the inherent
stochasticity of intracellular biological processes (see e.g. [31], [32]), these correlation values demonstrate
the relevance of the RFM in this context.
5A. Steady-State Spectral Representation
Ref. [30] has shown that the RFM is a tridiagonal cooperative dynamical system [33], and that (1)
admits a unique steady-state point e = e(λ0, . . . , λn) ∈ int(Cn) that is globally asymptotically stable, that
is, limt→∞ x(t, a) = e for all a ∈ Cn (see also [34]). This means that the ribosomal density profile always
converges to a steady-state profile that depends on the rates, but not on the initial condition. In particular,
the output rate R(t) = λnxn(t) converges to a steady-state value R := λnen.
At steady-state (i.e, for x = e), the left-hand side of all the equations in (1) is zero, so
λ0(1− e1) = λ1e1(1− e2)
= λ2e2(1− e3)
.
.
.
= λn−1en−1(1− en)
= λnen
= R. (3)
This yields
R = λiei(1− ei+1), i = 0, . . . , n, (4)
where e0 := 1 and en+1 := 0. Ref. [35] used these expressions to provide a spectral representation of
the mapping from the set of rates λ to the steady-state output rate R. Let Rn+ := {y ∈ Rn : yi ≥ 0, i =
1, . . . , n} and Rn++ := {y ∈ Rn : yi > 0, i = 1, . . . , n}.
Theorem 1 [35] Given an RFM with rates λ = [λ0 . . . λn]′, let R = R(λ) denote its steady-state
production rate. Define an (n + 2)× (n+ 2) Jacobi matrix A = A(λ) by
A :=


0 λ
−1/2
0 0 0 . . . 0 0
λ
−1/2
0 0 λ
−1/2
1 0 . . . 0 0
0 λ
−1/2
1 0 λ
−1/2
2 . . . 0 0
.
.
.
0 0 0 . . . λ
−1/2
n−1 0 λ
−1/2
n
0 0 0 . . . 0 λ
−1/2
n 0


. (5)
Then:
1) The eigenvalues of A are real and distinct, and if we order them as ζ1 < · · · < ζn+2 then ζn+2 =
(R(λ))−1/2.
2) Let si(λ) := ∂∂λiR(λ), i.e. the sensitivity of R with respect to (w.r.t.) the rate λi. Let v ∈ Rn+2++ denote
an eigenvector of A corresponding to the eigenvalue ζn+2. Then
si(λ) =
2R3/2
λ
3/2
i v
′v
vi+1vi+2, i = 0, . . . , n. (6)
This means that the steady-state production rate, and its sensitivity with respect to the transition rates,
can be computed efficiently using numerical algorithms for computing the eigenvalues and eigenvectors
of tridiagonal matrices. Theorem 1 also implies that
R(cλ0, . . . , cλn) = cR(λ0, . . . , λn), for all c > 0, (7)
i.e. R(λ) is homogeneous of degree one.
Another important implication of Theorem 1 is that R is a strictly concave function of the transition
rates {λ0, . . . , λn} over Rn+1++ [35]. Also, it implies that ∂∂λiR > 0 for all i, that is, an increase in any of
the rates yields an increase in the steady-state production rate.
For more on the analysis of the RFM, and also networks of interconnected RFMs, using tools from
systems and control theory, see e.g. [36], [35], [37], [38], [39], [40], [41].
6MAIN RESULTS
We begin by posing a general minimization problem for the steady-state production rate in the RFM.
Problem 1 Given a convex and compact feasible set of transition rates Ωn+1 ⊂ Rn+1++ , find λ∗ ∈ Ωn+1
such that R(λ∗) = minλ∈Ωn+1 R(λ).
From the biological point of view, the feasible set of transition rates Ωn+1 depends on all the biophysical
constraints on the transition rates along the coding sequence. For example, the maximal/minimal decoding
rate of a codon (e.g. via its adaptation to the tRNA pool) [42], the maximal possible effect of mRNA
folding (after codon substitution) on each codon [43], the maximal possible effect (after amino acid
substitution) of the interaction of the ribosome with amino acids of the nascent peptide [44], and the
maximal elongation slow down due to interaction with microRNAs [8], [9].
Below we explain how to pose various interesting biological problems in the framework of Problem 1.
Examples include finding the minimal number of mutations that down regulate translation of a gene/mRNA
under a certain “total reduction budget”. This is practically important when we use costly (in terms of
time and money) gene editing approaches. Another related question is how to down regulate translation of
a gene/mRNA with a maximal number of mutations. This is important when attenuating viral replication
rate for generating a safe live attenuated vaccine. A large number of mutations reduces the probability
of reverting. One may also define the feasible set in Problem 1 in such a way that some rates cannot be
changed. This is relevant for example when some codons along the mRNA cannot be modified. Indeed,
various positions along the mRNA affect regulatory mechanisms that we may not want to alter (e.g.
co-translational folding, splicing, translation).
It is well-known (see, e.g. [45, Thm. 7.42]) that if f : Ωn+1 → R is a continuous and strictly convex
function defined over a convex and compact set Ωn+1 then all the maximizers of f over Ωn+1 are extreme
points of Ωn+1 (for more on the problem of maximizing a convex function, or equivalently, minimizing
a concave function, see e.g. [46]). Combining this with the fact that R is a strictly concave function of
the transition rates over Rn+1++ implies the following.
Proposition 1 Every solution of Problem 1 is an extreme point of Ωn+1.
In particular, if the set of extreme points of Ωn+1 is finite then one can always solve Problem 1 by
simply calculating R(λ) for all λ that are extreme points of Ωn+1, and then finding the minimum of these
values. In particular, if Ωn+1 is a convex polytope then the extreme points are just the vertices of Ωn+1.
Thus, when the biophysical constraints lead to a feasible set of rates that is a convex polytope then it is
computationally straightforward to determine how to modify the rates so as to obtain the largest decrease
in translation rate under reasonable biophysical constraints.
In the remainder of this section, we consider three special cases of Problem 1 for which it is also
possible to obtain analytic results.
Problem 2 Given an RFM with n sites, rates λ¯0, . . . , λ¯n, and a “total reduction budget” b ∈ [0,min{λ¯i}],
let Ωn+1 = Ωn+1(λ¯, b) be the set{[
λ¯0 − ε0, . . . , λ¯n − εn
]
: εi ≥ 0,
n∑
i=0
εi = b
}
. (8)
Find λ∗ ∈ Ωn+1 such that R(λ∗) = minλ∈Ωn+1 R(λ).
In other words, Ωn+1 is the set of all the rates that can be obtained by applying a total reduction b to the
given rates λ¯i. From a mathematical point of view, b provides a bound on the total possible rate reduction.
It also couples the reduction in different rates, as a larger reduction in one rate must be compensated by
smaller reductions in other rates so that the total reduction will not exceed b. From a synthetic biology point
of view, b can be used to capture the idea of maximally inhibiting the production rate while minimizing
7the side-effects of this down regulation. For example, a very small value of b forces a solution with small
modifications in all the rates. This is expected of course to minimize the effect of the mutations on the
fitness of the cell/organism. For example, since co-translation folding [47], [48], [49] is related to the
ribosome transition rates along the mRNA, smaller changes in the rates are expected to have a smaller
effect on protein folding (and thus on the functionality of the protein and the overall organismal fitness).
Smaller changes in the transition rates are also related to a “simpler” biological solution in the sense of
fewer mutations, less miRNAs, etc.
The next example demonstrates Problem 2.
Example 1 Consider an RFM with dimension n = 4 and transition rates
λ¯0 = 0.85, λ¯1 = 0.92, λ¯2 = 0.78, λ¯3 = 0.57, λ¯4 = 0.88.
The steady-state production rate is R(λ¯0, . . . , λ¯4) = 0.2308 (all numbers are to four digit accuracy).
Suppose that the total reduction budget is b = 0.1. Then, for example, the vector
λ := λ¯−
[
0.05 0 0 0.02 0.03
]
,
belongs to Ω5, and R(λ) = 0.2260. An optimal solution is λ∗ :=
[
0.85 0.92 0.78 0.47 0.88
]′
∈ Ω5,
with R(λ∗) = 0.2140. Note that this corresponds to reducing b from the rate λ¯3, which is the minimum
of all the rates λ¯i, leaving all the other rates unchanged. 
Let di ∈ Rn+1 denote the (i+1)’th column of the (n+1)× (n+1) identity matrix. The set Ωn+1(λ¯, b)
is a convex polytope with vertices:
vi :=
[
λ¯0 . . . λ¯n
]′
− bdi, i = 0, . . . , n.
If there exists an index i such that λ¯i = b then it is clear that an optimal solution is to reduce λ¯i
to 0, as then the steady-state production rate will be zero. So we always assume that b takes values in
the set [0,min{λ¯i} − ρ], for some ρ > 0. This means that Problem 2 is a special case of Problem 1, as
Ωn+1(λ¯, b) is a convex polytope contained in Rn+1++ .
By Prop. 1, every solution of Problem 2 is contained in the set {v0, . . . , vn}. In other words, every
minimizer corresponds to reducing all the available budget b from a single rate. This immediately yields a
simple and efficient algorithm for solving Problem 2: use the spectral representation of R to compute R(vi),
i = 0, . . . , n, and then find the minimum of all these values. Since the matrix A in (5) is symmetric and
tridiagonal, calculating R(vi) can be done efficiently even for large values of n. We wrote a simple (and
unoptimized) MATLAB script for solving Problem 2, and ran it on a MAC laptop with a 2.6 GHz Intel
core i7 processor. For an RFM with n = 500 (a typical coding region includes a few hundred codons
[50]), rates λ¯i = 1, i = 0, . . . , 500, and b = 0.1, the optimal solution is found in 3.14 seconds.
Example 1 may suggest that reducing the slowest transition rate by b always yields an optimal solution,
but in general this is not true (see Example 3 below).
One may also consider a different feasible set in Problem 2, namely,{[
λ¯0 − ε0, . . . , λ¯n − εn
]
: εi ≥ 0,
n∑
i=0
εi ≤ b
}
,
i.e. here the total reduction is up to b. However, by Theorem 1 ∂
∂λi
R(λ) > 0 for all i, and thus an optimal
solution for this problem is guaranteed to agree with an optimal solution of Problem 2.
The next example demonstrates the effect of increasing the total reduction rate b on the optimal solution
of Problem 2.
Example 2 Consider an RFM with dimension n = 10, and rates λ¯i = 1, i = 0, . . . , n. Here R(λ¯) =
0.2652. We calculated the optimal solution λ∗ for different values of b, and also the value ∆R(b) :=
80 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
b
0
0.05
0.1
0.15
0.2
0.25
0.3
Fig. 3. ∆R as a function of b for an RFM with dimension n = 10 and rates λ¯i = 1, i = 0, . . . , 10.
R(λ¯)− R(λ∗), that is, the optimal reduction in protein rate that can be obtained for various values of b.
Figure 3 depicts ∆R as a function of b. It may be seen that ∆R increases quickly with b (specifically,
the relation is superlinear). 
B. Optimal reduction and sensitivities
It is also possible to derive theoretical results on the structure of an optimal solution λ∗ in Problem 2
using the sensitivities si(λ) := ∂∂λiR(λ). Note that these can be computed efficiently using (6).
Proposition 2 Consider Problem 2. If there exist i, j ∈ {0, . . . , n} such that
si(λ¯) < sj(λ¯) (9)
then any optimal solution λ∗ satisfies λ∗i = λ¯i.
In other words, if the sensitivity of the steady-state production rate to rate λi at λ¯ is lower than some other
sensitivity then an optimal solution will not include a reduction in λ¯i. Indeed, it is better to distribute the
reduction budget over some other, more sensitive, rates.
Remark 1 Note that since R is a strictly concave function of the rates,
∂
∂λi
si(λ¯) =
∂2
∂λ2i
R(λ¯) < 0,
for any λ¯ ∈ Rn+1++ and any i ∈ {0, . . . , n}. In other words, a decrease in λ¯i increases the sensitivity w.r.t.
this rate.
Proposition 2 leads to the following definition.
Definition 1 Given an RFM with rates λ¯, a transition rate λ¯j is called a bottleneck rate if sj(λ¯) > si(λ¯),
for all i 6= j.
In other words, a bottleneck rate is one with a maximal sensitivity.
Combining this with Proposition 2 immediately yields the following result.
9Corollary 1 Given an RFM with rates λ¯, suppose that sj(λ¯) is a bottleneck rate. Then the unique optimal
solution to Problem 2 is obtained by reducing λ¯j by b.
An important observation is that the slowest rate along the mRNA molecule and the bottleneck rate
may be different. The next example demonstrates this.
Example 3 Consider an RFM with dimension n = 4, and rates λ¯3 = 1.85, λ¯i = 2.0, i = 0, 1, 2, 4. In
this case, s0(λ¯) = 0.0297, s1(λ¯) = 0.0687, s2(λ¯) = 0.0901, s3(λ¯) = 0.0856, and s4(λ¯) = 0.0343. Thus,
although the minimal rate is λ¯3, the bottleneck rate is λ¯2. In particular, the optimal solution will be to
reduce λ¯2 by b, and not λ¯3, even though λ¯3 is the minimal rate. 
However, note that Remark 1 implies that if some rate λi is decreased enough then it will eventually
become a bottleneck rate.
Proposition 2 can be used to derive analytic results in cases where we can obtain explicit information
on the sensitivities at a point λ¯ ∈ Rn+1+ . The next two results demonstrate this.
Proposition 3 Consider an RFM with dimension n and with equal rates, i.e. λ¯0 = · · · = λ¯n. If n is even
then the unique optimal solution to Problem 2 is: λ∗ = λ¯− bdn/2. If n is odd then there are two optimal
solutions: λ∗ = λ¯− bd⌊n/2⌋ and λ∗ = λ¯− bd⌊n/2⌋+1.
In other words, in the case where all the rates are equal, the bottleneck is at the center of the chain.
These results are closely related to the fact that in a dynamic model for phosphorelay [51], that is very
similar to the RFM, the middle layer in the model is the most sensitive to changes in the input. This also
agrees with the so called “edge-effect” in the HTASEP [52], [53], [54], i.e. the fact that the steady-state
output rate is less sensitive to the rates that are close to the edges of the chain. For more on the sensitivity
of TASEP to manipulations in the initiation, hopping, and exit rates, see [54], [55], [56], [57].
Another case where analytic results can be derived is when the rates in the RFM lead to equal steady-
state occupancies along the mRNA molecule. This happens when λ1 = λ2 = · · · = λn−1 = λ0 + λn
(see (3)).
Proposition 4 Consider an RFM with dimension n and rates λ¯ such that e¯1 = · · · = e¯n := ec, i.e. all the
steady-state occupancies are equal, and ec denotes their common value.
1) If ec < 1/2 then the unique optimal solution to Problem 2 is
λ∗ = λ¯− bd0. (10)
2) If ec > 1/2 then the unique optimal solution to Problem 2 is
λ∗ = λ¯− bdn. (11)
3) If ec = 1/2 then (10) and (11) are the optimal solutions.
In other words, if the equal occupancy is relatively low [high] then maximal inhibition of the production
rate is obtained by reducing the total reduction rate from the initiation [exit] rate, leaving all the other
rates unchanged. .
Example 4 Consider Problem 2 for an RFM with n = 5, rates λ¯ =
[
1 5/2 5/2 5/2 5/2 3/2
]′
,
and b = 1/2. Note that in this case e¯1 = · · · = e¯5 = 2/5. A calculation yields R(λ¯ − bd0) = 0.3999,
R(λ¯−bd1) = 0.5651, R(λ¯−bd2) = 0.5762, R(λ¯−bd3) = 0.5829, R(λ¯−bd4) = 0.5874, and R(λ¯−bd5) =
0.5746, so the optimal solution is λ∗ = λ¯− bd0. Since ec < 1/2, this agrees with Proposition 4. 
In some cases it may be more natural to define the transition rate reduction in relative rather than
absolute terms. This is captured by the following optimization problem.
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Problem 3 Given an RFM with n sites, rates λ¯0, . . . , λ¯n, and a total reduction budget q ∈ [0, 1),
let Γn+1 = Γn+1(λ¯, q) ⊂ Rn+1++ be the set{[
λ¯0(1− δ0), . . . , λ¯n(1− δn)
]
: δi ≥ 0,
n∑
i=0
δi = q
}
. (12)
Find λ∗ ∈ Γn+1 such that R(λ∗) = minλ∈Γn+1 R(λ).
For i ∈ {0, . . . , n}, let Di ∈ R(n+1)×(n+1) denote the (n+1)× (n+1) identity matrix, but with entry (i+
1, i+1) changed to 1− q. The set Γn+1 is a convex polytope with vertices ui := Diλ¯, i = 0, . . . , n. Thus,
Problem 3 is also a special case of Problem 1, and so the minimizer λ∗ satisfies λ∗ ∈ {u0, . . . , un}.
In practice, each codon (or coding region) admits a minimal and a maximal possible decoding rate.
There are also minimal and maximal values for the initiation rate. These bounds are determined by the
biophysical properties of the transcript and the intracellular environment. To model this, we can modify
the optimization problems described above to include a bound ℓi on the maximal allowed reduction of
rate i, for i = 0, . . . , n. The next problem demonstrates such a modification for Problem 2.
Problem 4 Consider an RFM with n sites and rates λ¯0, . . . , λ¯n. Given a total reduction budget b ∈
[0,min{λ¯i} − ρ], for some ρ > 0, and also bounds 0 < ℓi < λ¯i, i = 0, . . . , n, with
∑n
i=0 ℓi > b, let Ωn+1
be as defined in Problem 2, and let
Ψn+1 := {λ ∈ Rn+1++ : λi ∈ [λ¯i − ℓi, λ¯i], i = 0, . . . , n},
Φn+1 := Ωn+1 ∩Ψn+1. (13)
Find λ∗ ∈ Φn+1 such that R(λ∗) = minλ∈Φn+1 R(λ).
In other words, the feasible set Φn+1 in Problem 4 is the intersection of the set Ωn+1 (defined in Problem 2),
and the closed (n+1)-dimensional cube Ψn+1 that models constraints on the maximal possible reduction
of each rate.
Since Φn+1 is compact and convex (being the intersection of two compact and convex sets), Problem 4
admits a solution that is an extreme point of Φn+1. In general, not all the rates can be reduced by b, and
thus an optimal solution may include a reduction of several rates.
Example 5 Consider Problem 4 for an RFM with dimension n = 2, rates λ¯i = 1.0, i = 0, 1, 2, and
parameters b = 0.85, and ℓi = 0.4, i = 0, 1, 2. In other words, the total possible reduction is 0.85, but any
rate can be reduced by no more than 0.4. Fig. 4 depicts the feasible set Φ3 (blue polytope) that is the
intersection of the set Ω3 (gray polytope) and the set Ψ3 (green cube). Shown also are the three extreme
points of Φ3:
v1 :=
[
0.95 0.6 0.6
]′ (red circle) ,
v2 :=
[
0.6 0.6 0.95
]′ (blue circle),
v3 :=
[
0.6 0.95 0.6
]′ (magenta circle).
A calculation yields R(v1) = R(v2) = 0.2538, whereas R(v3) = 0.2764. It follows that λ∗ = v1 and
λ∗ = v2 are optimal solutions. Note that these solutions correspond to reducing several rates along the
mRNA molecule. Note also that s(λ¯) =
[
0.1056 0.1708 0.1056
]′
, so both optimal solutions correspond
to a maximal possible reduction in a most sensitive rate, and a maximal possible reduction in another
most sensitive rate. 
In some cases, there may be positions along the coding region that we cannot modify due to their
potential effect on various intracellular processes. An important advantage of Problem 4 is that it allows
capturing this by simply setting some of the ℓis to zero.
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Fig. 4. The sets Ω3 (gray polytope), Ψ3 (green cube), and Φ3 (blue polytope) in Example 5.
On the other hand, in down regulation of a viral gene it may be desirable to distribute the synonymous
codon modifications over many mRNA sites in order to reduce the chance of spontaneous mutations
yielding the original wild type. This is captured by Problem 4 when we set the ℓis to small non-zero
values, as then an optimal solution will include a transition rate reduction in many sites.
C. A biological example
To demonstrate how the results above can be used to analyze translation and provide guidelines for
re-engineering the mRNA, we consider the S. cerevisiae gene YBL025W that encodes the protein RRN10
which is related to regulation of RNA polymerase I. This gene has 145 codons (excluding the stop codon).
Similarly to the approach used in [28], we divided this mRNA into 6 consecutive pieces: the first piece
includes the first 24 codons (that are also related to later stages of initiation [49]). The other pieces
include 25 non-overlapping codons each, except for the last one that includes 21 codons.
To model this using an RFM with n = 5 sites, we first estimated the elongation rates λ1, . . . , λ5 using
ribo-seq data for the codon decoding rates [42], normalized so that the median elongation rate of all S.
cerevisiae mRNAs becomes 6.4 codons per second [58]. The site rate is (site time)−1, where site time
is the sum over the decoding times of all the codons in this site. These rates thus depend on various
factors including availability of tRNA molecules, amino acids, Aminoacyl tRNA synthetase activity and
concentration, and local mRNA folding [42], [1], [49]. Note that if we replace a codon in a site of mRNA
by a synonymous slower codon then the decoding time increases and thus the rate associated with this
site decreases.
The initiation rate (that corresponds to the first piece) was estimated based on the ribosome density
per mRNA levels, as this value is expected to be approximately proportional to the initiation rate when
initiation is rate limiting [28], [59]. Again we applied a normalization that brings the median initiation
rate of all S. cerevisiae mRNAs to be 0.8 [60]. Adding the initiation time (1/0.4482) to the site time of
the first piece yields an RFM model with n = 5 and parameters:[
λ¯0 . . . λ¯5
]
=
[
0.1678 0.2572 0.2758 0.2514 0.2612 0.3002
]
.
A calculation yields that the steady-state production rate in this RFM is R = 0.0732.
12
In order to analyze the solution of Problem 2 for this RFM we calculated the sensitivities using (6).
This yields: s(λ¯) =
[
0.0795 0.0669 0.0611 0.0578 0.0328 0.0092
]
, so λ¯0 is a bottleneck rate. This
means that the solution for Problem 2 is to reduce all the reduction budget b from λ¯0. In biological
terms, this suggests that maximal inhibition of production should be based on replacing some (or all)
of the first 24 codons with slower synonymous codons. For comparison with the optimization scenarios
described below, consider the total budget b = 0.0089. The solution for Problem 2 is then to reduce λ0
by b, and this yields
R∗ = 0.0725. (14)
Reducing λ0 by b in the model is possible by substituting codons in the first site with their slowest synony-
mous mutation (for example, the third codon AGA should be replaced by the synonymous codon CGG,
increasing the codon decoding time from 0.1128 seconds to 0.2246 seconds).
Now suppose that we are not interested in modifying these codons because in this region there are
various regulatory signals that we may not want to change (see, for example, [49]). To maximize inhibition
of production rate under this constraint, we apply Problem 4, with ℓ0 = 0, and ℓi > b for all i 6= 0. Now
the optimal solution is to reduce b from λ¯1. Note that λ¯1 has the second largest sensitivity. This yields
R∗ = 0.0726, and is, as expected, higher than the value in (14). Again, the biological data shows that
such a reduction can be done by synonymously replacing codons 34 (GCT with GCA), 35 (GTT with
GTA), 36 (CCT with CCC), 38 (CCG with CCC), 39 (TTC with TTT), and 49 (GTG with GTA).
Finally, to demonstrate mutations in multiple sites, we used the data to find a scenario where a set of
mutations yields the same total decrease in the rates. This can be done by synonymously replacing codons
21 (GTG with GTA), 29 (GAA with GAG), 58 (TTC with TTT), 82 (AAG with AAA), 110 (CTA with
CTG), and 141 (GCG with GCA), leading to
λ =
[
0.1677 0.2557 0.2733 0.2489 0.2599 0.2991
]′
.
Note that all the rates are reduced and that the total reduction is b. This yields R = 0.0727, which is
again higher than the value in (14).
DISCUSSION
There are several approaches for effectively down-regulating translation. Global down-regulation can
be achieved by controlling basic translation factors or by using drugs that induce ribosome stalling [61],
[62], [63]. Here we consider down regulation of specific genes via targeting specific codons/regions in
these genes. This leads to the problem of finding the codon regions that have the most effect on the
steady-state production rate. We study this problem of optimal down regulation of mRNA translation
using a mathematical model for ribosome flow, the RFM. All possible modifications of the rates define
a feasible set of rates, and, under certain conditions, we give a simple algorithm for finding the optimal
solution, that is, the rates that lead to a maximal decrease in the protein production rate. For some specific
cases, we also derive theoretical results on the optimal solution.
Our results show that the solution must focus on the positions along the mRNA molecule where
the transition rate has the strongest effect on the protein production rate. However, this position is not
necessarily the one with the minimal rate (though in many cases there are correlations between the two
definitions). Many previous studies in the field emphasized the importance of the translation bottleneck
[64], [21], [56], however, this is always defined as the minimal rate. We believe that the sensitivity of the
coding region sites should be further studied in order to understand better the evolution of transcripts and
their design.
The optimization problems posed here are flexible enough to capture various scenarios. For example, in
some cases it may be desirable to introduce a minimal number of changes in the transcript to obtain the
desired decrease in the translation rate. Indeed, generating mutations and using suitable RNAi molecules is
costly in time and money. Also, any change in the translation rates can affect various important phenomena
such as co-translational folding [47], [48], [49], as well as other properties that are encoded in the coding
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region [49], [65], [66]. In other cases, such as generating a down-regulated virus strain, it may be desirable
to introduce as many mutations as possible.
There are various approaches for synthesizing molecules that block mRNA translation (see e.g. http://www.gene-tools.com/choosing the optimal target).
In practice, when determining an optimal position to target (e.g. with RNAi molecules) one must take
into account additional biophysical aspects. For example, the GC content at the different regions along
the mRNA, the folding of the mRNA, the potential binding affinity of the RNAi and the mRNA, potential
un-desired binding of the RNAi to additional mRNAs or regions within the mRNA, etc. Nevertheless, we
feel that out results can be integrated to improve the design of such tools.
In practice, there are many mRNA molecules in the cell and they all compete for the finite pool of
free ribosomes. In particular, if more ribosomes are stuck in a traffic jam on a certain mRNA molecule
then the pool of free ribosomes is depleted yielding a reduction in the production rates in other mRNA
molecules. The RFM is a model for ribosome flow along a single isolated mRNA molecule. This is a
reasonable model when the expression levels (e.g. the mRNA levels and the total number of ribosomes on
the mRNA molecules related to the gene) are relatively low, so that changes in the translation dynamics
on one mRNA have a negligible effect on the pool of ribosomes and thus on the other mRNAs. A model
for a network of RFMs, interconnected via a dynamic pool of free ribosomes, has been studied in [41].
It may be of interest to study the problem of down regulation of a specific mRNA molecule within this
framework. In this case, one can also down regulate the mRNA indirectly by affecting the ribosomal
pool. However, the tools used here do not directly apply, as the convexity results for a single chain do
not necessarily carry over to the case of a network of RFMs.
The results here suggest several biological experiments for studying the problem of optimal down
regulation and, in particular, validating the theoretical predictions derived using the RFM. Libraries
encoding the same protein using mRNAs with different codons (but similar mRNA levels and translation
initiation rates) can be generated as was done in [16]. For each variant the protein levels, that are expected
to monotonically increase with the production rate [28], can be measured either via a reporter protein [16]
or directly [67]. The codon decoding rates can be estimated based on ribo-seq experiments [16], [42].
Such an experimental testbed can be used to validate the results reported in this study.
APPENDIX: PROOFS
Proof of Proposition 2. Consider Problem 2, and suppose that (9) holds. We need to show that λ∗i = λ¯i.
Seeking a contradiction, assume that λ∗i < λ¯i. By Prop. 1, λ∗ = λ¯ − bdi, so in particular R(λ¯ − bdi) ≤
R(λ¯−bdj). Since R is a homogeneous function of the rates, we conclude that R(cλ¯−cbdi) ≤ R(cλ¯−cbdj)
for any c > 0. Now taking c > 0 sufficiency small yields ∂R(λ¯)
∂λi
≥ ∂R(λ¯)
∂λj
. This contradicts (9).
Proof of Proposition 3. In the case where all the rates are equal there exists a closed-form expression
for the sensitivities [37], namely,
si =
sin
(
i+1
n+3
π
)
sin
(
i+2
n+3
π
)
2(n+ 3) cos3
(
pi
n+3
) , i = 0, . . . , n.
This means that
si =
a− cos
(
2i+3
n+3
π
)
b
, (15)
where a, b > 0 are constants that do not depend on i. If n is even then the cosine function in (15) admits
a unique minimum at i = n/2, and combining this with Proposition 2 completes the proof. If n is odd
then the cosine function in (15) admits two minima: at ⌊n/2⌋ and at ⌊n/2⌋ + 1. Now arguing as in the
proof of Proposition 2 and using the particle-hole symmetry of the RFM completes the proof.
Proof of Proposition 4. If e¯1 = · · · = e¯n := ec, then (3) yields
λ¯i =


1, i = 0,
e−1c , i = 1, . . . , n− 1,
e−1c − 1, i = n,
(16)
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where we scaled λ¯0 to one w.l.o.g. In this case, the Perron eigenvector v ∈ Rn+2++ of the matrix A(λ¯) is
given by (see also [37]):
vi =


1, i = 1,
µ(i−1)/2e
−1/2
c , 2 ≤ i ≤ n+ 1,
µn/2, i = n+ 2,
(17)
where µ := ec/(1− ec). We consider two cases.
If ec = 1/2 then v′v = 2(n+ 1) and applying Theorem 1 yields the sensitivities:
si =


1
2(n+1)
, i = 0,
1
4(n+1)
, 1 ≤ i ≤ n− 1,
1
2(n+1)
, i = n.
(18)
Thus, s0 = sn > sj , for all j 6∈ {0, n}, and arguing as in the proof of Proposition 2 and using the
particle-hole symmetry implies that the two optimal solutions are λ¯− bd0 and λ¯− bdn.
If ec 6= 1/2 then Theorem 1 yields
si =


1−2ec
1−µn+1
, i = 0,
ec(1−2ec)
1−µn+1
µi, 1 ≤ i ≤ n− 1,
µn+1(1−2ec)
1−µn+1
i = n.
(19)
When ec < 1/2 [ec > 1/2] (19) yields s0 > sj , for all j 6= 0 [sn > sj , for all j 6= n]. Combining this
with Proposition 2 completes the proof.
REFERENCES
[1] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, Molecular Biology of the Cell. New York: Garland Science,
2002.
[2] Y. Arava, Y. Wang, J. D. Storey, C. L. Liu, P. O. Brown, and D. Herschlag, “Genome-wide analysis of mRNA translation profiles in
Saccharomyces cerevisiae,” Proceedings of the National Academy of Sciences, vol. 100, no. 7, pp. 3889–3894, 2003.
[3] N. T. Ingolia, S. Ghaemmaghami, J. R. Newman, and J. S. Weissman, “Genome-wide analysis in vivo of translation with nucleotide
resolution using ribosome profiling,” Science, vol. 324, no. 5924, pp. 218–23, 2009.
[4] X. Yan, T. A. Hoek, R. D. Vale, and M. E. Tanenbaum, “Dynamics of translation of single mRNA molecules in vivo,” Cell, vol. 165,
no. 4, pp. 976–89, 2016.
[5] B. Wu, C. Eliscovich, Y. Yoon, and R. Singer, “Translation dynamics of single mRNAs in live cells and neurons,” Science, vol. 352,
no. 6292, pp. 1430–5, 2016.
[6] T. Morisaki, K. Lyon, K. F. DeLuca, J. G. DeLuca, B. P. English, Z. Zhang, L. D. Lavis, J. B. Grimm, S. Viswanathan, L. L. Looger,
T. Lionnet, and T. J. Stasevich, “Real-time quantification of single RNA translation dynamics in living cells,” Science, vol. 352, no.
6292, pp. 1425–9, 2016.
[7] C. Wang, B. Han, R. Zhou, and X. Zhuang, “Real-time imaging of translation on single mRNA transcripts in live cells,” Cell, vol.
165, no. 4, pp. 990–1001, 2016.
[8] M. Ghildiyal and P. Zamore, “Small silencing RNAs: an expanding universe,” Nature Rev. Genet., vol. 10, pp. 94–108, 2009.
[9] M. Inui, G. Martello, and S. Piccolo, “MicroRNA control of signal transduction,” Nat Rev Mol Cell Biol., vol. 11, no. 4, pp. 252–263,
2010.
[10] M. Fabian, N. Sonenberg, and W. Filipowicz, “Regulation of mRNA translation and stability by microRNAs,” Annu Rev Biochem.,
vol. 79, pp. 351–79, 2010.
[11] W. Filipowicz, S. Bhattacharyya, and N. Sonenberg, “Mechanisms of post-transcriptional regulation by microRNAs: are the answers
in sight?” Nat Rev Genet., vol. 9, no. 2, pp. 102–14, 2008.
[12] C. Croce, “Causes and consequences of microRNA dysregulation in cancer,” Nat Rev Genet., vol. 10, no. 10, pp. 704–14, 2009.
[13] S. Tavazoie, C. Alarco´n, T. Oskarsson, D. Padua, Q. Wang, P. Bos, and W. G. J. Massague´, “Endogenous human microRNAs that
suppress breast cancer metastasis,” Nature, vol. 451, no. 7175, pp. 147–52, 2008.
[14] L. Zhang, N. Yang, A. Mohamed-Hadley, S. Rubin, and G. Coukos, “Vector-based RNAi, a novel tool for isoform-specific knock-down
of VEGF and anti-angiogenesis gene therapy of cancer,” Biochem Biophys Res Commun., vol. 303, no. 4, pp. 1169–78, 2003.
[15] G. Devi, “siRNA-based approaches in cancer therapy,” Cancer Gene Ther., vol. 13, no. 9, pp. 819–29, 2006.
[16] T. Ben-Yehezkel, S. Atar, H. Zur, A. Diament, E. Goz, T. Marx, R. Cohen, A. Dana, A. Feldman, E. Shapiro, and T. Tuller, “Rationally
designed, heterologous S. cerevisiae transcripts expose novel expression determinants,” RNA Biol., vol. 12, pp. 972–84, 2015.
[17] E. Goz and T. Tuller, “Widespread signatures of local mRNA folding structure selection in four Dengue virus serotypes,” BMC
Genomics, vol. 16, no. Suppl 10:S4., 2015.
15
[18] Q. Wang, C. Contag, H. Ilves, B. Johnston, and R. Kaspar, “Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene
expression in human tissue culture cells and a mouse model,” Molecular Therapy, vol. 12, no. 3, pp. 562–8, 2005.
[19] J. Coleman, D. Papamichail, S. Skiena, B. Futcher, E. Wimmer, and S. Mueller, “Virus attenuation by genome-scale changes in codon
pair bias,” Science, vol. 320, pp. 1784–7, 2008.
[20] J. Perez, A. Pham, M. Lorini, M. Chua, J. Steel, and B. tenOever, “MicroRNA-mediated species-specific attenuation of influenza A
virus,” Nat Biotechnol., vol. 27, no. 6, pp. 572–6, 2009.
[21] T. Tuller, A. Carmi, K. Vestsigian, S. Navon, Y. Dorfan, J. Zaborske, T. Pan, O. Dahan, I. Furman, and Y. Pilpel, “An evolutionarily
conserved mechanism for controlling the efficiency of protein translation,” Cell, vol. 141, no. 2, pp. 344–54, 2010.
[22] J. Forman, A. Legesse-Miller, and H. Coller, “A search for conserved sequences in coding regions reveals that the let-7 microRNA
targets Dicer within its coding sequence,” Proceedings of the National Academy of Sciences, vol. 105, no. 39, pp. 14 879–84, 2008.
[23] P. Fang, C. Spevak, C. Wu, and M. Sachs, “A nascent polypeptide domain that can regulate translation elongation,” Proceedings of the
National Academy of Sciences, vol. 101, no. 12, pp. 4059–64, 2004.
[24] L. B. Shaw, R. K. P. Zia, and K. H. Lee, “Totally asymmetric exclusion process with extended objects: a model for protein synthesis,”
Phys. Rev. E, vol. 68, p. 021910, 2003.
[25] R. Zia, J. Dong, and B. Schmittmann, “Modeling translation in protein synthesis with TASEP: A tutorial and recent developments,” J.
Statistical Physics, vol. 144, pp. 405–428, 2011.
[26] A. Schadschneider, D. Chowdhury, and K. Nishinari, Stochastic Transport in Complex Systems: From Molecules to Vehicles. Elsevier,
2011.
[27] S. Srinivasa and M. Haenggi, “A statistical mechanics-based framework to analyze ad hoc networks with random access,” IEEE Trans.
Mobile Computing, vol. 11, pp. 618–630, 2012.
[28] S. Reuveni, I. Meilijson, M. Kupiec, E. Ruppin, and T. Tuller, “Genome-scale analysis of translation elongation with a ribosome flow
model,” PLOS Computational Biology, vol. 7, p. e1002127, 2011.
[29] R. A. Blythe and M. R. Evans, “Nonequilibrium steady states of matrix-product form: a solver’s guide,” J. Phys. A: Math. Theor.,
vol. 40, no. 46, pp. R333–R441, 2007.
[30] M. Margaliot and T. Tuller, “Stability analysis of the ribosome flow model,” IEEE/ACM Trans. Computational Biology and
Bioinformatics, vol. 9, pp. 1545–1552, 2012.
[31] A. Diament and T. Tuller, “Ribosome profiling resolution in practice,” under review, 2016.
[32] M. Kaern, T. C. Elston, W. J. Blake, and J. J. Collins, “Stochasticity in gene expression: from theories to phenotypes,” Nat Rev Genet.,
vol. 6, pp. 451–64, 2005.
[33] H. L. Smith, Monotone Dynamical Systems: An Introduction to the Theory of Competitive and Cooperative Systems, ser. Mathematical
Surveys and Monographs. Providence, RI: Amer. Math. Soc., 1995, vol. 41.
[34] M. Margaliot, E. D. Sontag, and T. Tuller, “Entrainment to periodic initiation and transition rates in a computational model for gene
translation,” PLoS ONE, vol. 9, no. 5, p. e96039, 2014.
[35] G. Poker, Y. Zarai, M. Margaliot, and T. Tuller, “Maximizing protein translation rate in the nonhomogeneous ribosome flow model: A
convex optimization approach,” J. Royal Society Interface, vol. 11, no. 100, p. 20140713, 2014.
[36] Y. Zarai, M. Margaliot, and T. Tuller, “Explicit expression for the steady-state translation rate in the infinite-dimensional homogeneous
ribosome flow model,” IEEE/ACM Trans. Computational Biology and Bioinformatics, vol. 10, pp. 1322–1328, 2013.
[37] G. Poker, M. Margaliot, and T. Tuller, “Sensitivity of mRNA translation,” Sci. Rep., vol. 5, no. 12795, 2015.
[38] Margaliot, M. and Tuller, T., “Ribosome flow model with positive feedback,” J. Royal Society Interface, vol. 10, p. 20130267, 2013.
[39] A. Raveh, Y. Zarai, M. Margaliot, and T. Tuller, “Ribosome flow model on a ring,” IEEE/ACM Trans. Computational Biology and
Bioinformatics, vol. 12, no. 6, pp. 1429–1439, 2015.
[40] Y. Zarai, M. Margaliot, E. D. Sontag, and T. Tuller, “Controlling mRNA translation,” 2016, Submitted. [Online]. Available:
http://arxiv.org/abs/1602.02308
[41] A. Raveh, M. Margaliot, E. D. Sontag, and T. Tuller, “A model for competition for ribosomes in the cell,” J. Royal Society Interface,
vol. 13, no. 116, 2016.
[42] A. Dana and T. Tuller, “Mean of the typical decoding rates: a new translation efficiency index based on ribosome analysis data,” G3:
Genes, Genomes, Genetics, 2014.
[43] T. Tuller, I. Veksler, N. Gazit, M. Kupiec, E. Ruppin, and M. Ziv, “Composite effects of the coding sequences determinants on the
speed and density of ribosomes,” Genome Biol., vol. 12, no. 11, p. R110, 2011.
[44] R. Sabi and T. Tuller, “A comparative genomics study on the effect of individual amino acids on ribosome stalling,” BMC Genomics,
vol. 16, p. S5, 2015.
[45] A. Beck, Introduction to Nonlinear Optimization: Theory, Algorithms, and Applications with MATLAB. Philadelphia, PA: Society for
Industrial and Applied Mathematics, 2014.
[46] R. Enhbat, “An algorithm for maximizing a convex function over a simple set,” J. Global Optimization, vol. 8, no. 4, pp. 379–391,
1996.
[47] G. Zhang, M. Hubalewska, and Z. Ignatova, “Transient ribosomal attenuation coordinates protein synthesis and co-translational folding,”
Nat Struct Mol Biol., vol. 16, no. 3, pp. 274–80, 2009.
[48] S. Pechmann and J. Frydman, “Evolutionary conservation of codon optimality reveals hidden signatures of cotranslational folding,”
Nat Struct Mol Biol., vol. 20, no. 2, pp. 237–43, 2013.
[49] T. Tuller and H. Zur, “Multiple roles of the coding sequence 5’ end in gene expression regulation,” Nucleic Acids Res., vol. 43, no. 1,
pp. 13–28, 2015.
[50] J. Zhang, “Protein-length distributions for the three domains of life,” Trends Genet., vol. 16, no. 3, pp. 107–9, 2000.
[51] A. Csikasz-Nagy, L. Cardelli, and O. S. Soyer, “Response dynamics of phosphorelays suggest their potential utility in cell signaling,”
J. Royal Society Interface, vol. 8, pp. 480–488, 2011.
16
[52] J. J. Dong, B. Schmittmann, and R. K. P. Zia, “Towards a model for protein production rates,” J. Statistical Physics, vol. 128, no. 1-2,
pp. 21–34, 2007.
[53] J. J. Dong, R. K. P. Zia, and B. Schmittmann, “Understanding the edge effect in TASEP with mean-field theoretic approaches,” J.
Phys. A: Math. Gen., vol. 42, no. 1, p. 015002, 2009.
[54] J. J. Dong, B. Schmittmann, and R. K. P. Zia, “Inhomogeneous exclusion processes with extended objects: The effect of defect
locations,” Phys. Rev. E, vol. 76, p. 051113, 2007.
[55] M. E. Foulaadvand, A. B. Kolomeisky, and H. Teymouri, “Asymmetric exclusion processes with disorder: Effect of correlations,”
Physical Review E, vol. 78, no. 6, p. 061116, 2008.
[56] T. Chou and G. Lakatos, “Clustered bottlenecks in mRNA translation and protein synthesis,” Phys. Rev. Lett., vol. 93, p. 198101, 2004.
[57] G. Tripathy and M. Barma, “Driven lattice gases with quenched disorder: exact results and different macroscopic regimes,” Phys. Rev.
E, vol. 58, pp. 1911–1926, 1998.
[58] T. V. Karpinets, D. J. Greenwood, C. E. Sams, and J. T. Ammons, “RNA:protein ratio of the unicellular organism as a characteristic of
phosphorous and nitrogen stoichiometry and of the cellular requirement of ribosomes for protein synthesis,” BMC Biol., vol. 4, no. 30,
pp. 274–80, 2006.
[59] M. Margaliot and T. Tuller, “On the steady-state distribution in the homogeneous ribosome flow model,” IEEE/ACM Trans.
Computational Biology and Bioinformatics, vol. 9, pp. 1724–1736, 2012.
[60] D. Chu, E. Kazana, N. Bellanger, T. Singh, M. F. Tuite, and T. von der Haar, “Translation elongation can control translation initiation
on eukaryotic mRNAs,” EMBO J., vol. 33, no. 1, pp. 21–34, 2014.
[61] M. Greenberg, A. Hermanowski, and E. Ziff, “Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and
actin gene transcription,” Mol Cell Biol., vol. 6, no. 4, pp. 1050–7, 1986.
[62] M. Clemens, M. Bushell, I. Jeffrey, V. Pain, and S. Morley, “Translation initiation factor modifications and the regulation of protein
synthesis in apoptotic cells,” Cell Death Differ., vol. 7, no. 7, pp. 603–15, 2000.
[63] M. Kozak, “Regulation of translation in eukaryotic systems,” Annu Rev Cell Biol., vol. 8, pp. 197–225, 1992.
[64] S. Z. Zubay, E. Goldman, and G., “Clustering of low usage codons and ribosome movement,” J. Theor. Biol., vol. 170, pp. 339–54,
1994.
[65] L. Cartegni, S. Chew, and A. Krainer, “Listening to silence and understanding nonsense: exonic mutations that affect splicing,” Nat.
Rev. Genet., vol. 3, pp. 285–98, 2002.
[66] A. Stergachis, E. Haugen, A. Shafer, W. Fu, B. Vernot, A. Reynolds, A. Raubitschek, S. Ziegler, E. LeProust, J. Akey, and
J. Stamatoyannopoulos, “Exonic transcription factor binding directs codon choice and affects protein evolution,” Science, vol. 342,
pp. 1367–72, 2013.
[67] B. Schwanhausser, D. Busse, N. Li, G. Dittmar, J. Schuchhardt, J. Wolf, W. Chen, and M. Selbach, “Global quantification of mammalian
gene expression control,” Nature, vol. 473, no. 7347, pp. 1367–72, 2011.
